Market Overview

UPDATE: Jefferies Raises PT on CME Group on 1Q13 Exchange Preview

Related CME
Fast Money Picks For September 18 - Metlife Inc, CME Group Inc And More
UPDATE: GFI Issues Response to Unsolicited Bid from BGC, Sees Offer as Reasonably Leading to Superior Proposal, Continues to support Deal with CME
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $65.00 to $69.00.

In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.”

CME Group closed on Friday at $60.48.

Latest Ratings for CME

DateFirmActionFromTo
Sep 2014Keefe Bruyette & WoodsMaintainsOutperform
Sep 2014Deutsche Bank
Sep 2014Deutsche BankInitiates Coverage onBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters